A Change in REMS Requirements
The US Food and Drug Administration (FDA) has lifted the Risk Evaluation and Mitigation Strategy (REMS) requirements for certain medications used to treat anemia.
FDA Approves First Test for Group of Human Retroviruses
The U.S. Food and Drug Administration today approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II).
HPV Shot Not Linked to Blood Clots
One of the few vaccines that can actually protect against cancer is the human papillomavirus (HPV) vaccine, which prevents four strains of HPV. But some parents have expressed concerns about the safety of the HPV vaccine.
New Vaccine Recommendation for Adults
Adults with certain immune system conditions often require different recommendations for the vaccines they can and should receive. A new vaccine has been added to these recommendations.
FDA approves new indication for Promacta
GlaxoSmithKline announced today that the US Food and Drug Administration (FDA) has approved PROMACTA ® for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Merck Reports Phase III Results With Vicrelis
Merck announced final results from a Phase III, open-label study designed to compare the impact of two anemia management strategies on sustained virologic response ( SVR ) in patients with chronic hepatitis C virus ( HCV ) genotype 1 infection treated with VICTRELIS ( boceprevir ) in combination with PEGINTRON ( peginterferon alfa-2b ) and ribavirin (P/R).
Immune Cells Tactics: Divide and Conquer
Scientists understand the big picture of how vaccines work in the body but not all the specifics at the cellular level. Now they have discovered one more piece of the puzzle.
The Gift that Keeps on Giving
Have you saved a life this month? It's not too late. January is Blood Donor Month, so find your local donation center, hold out your arm and look the other direction.